TheraRadar
← Back
Data updated: Jul 17, 2026

INTERPHARMA PRAHA AS

Pharma
Pharmaceuticals

INTERPHARMA PRAHA AS is a pharmaceutical company with 1 FDA-approved products.

2015
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

INTERPHARMA PRAHA AS's Key Drugs

INTERPHARMA PRAHA AS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

INTERPHARMA PRAHA AS's Recent FDA Approvals

New NDA/BLA approvals for INTERPHARMA PRAHA AS over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

INTERPHARMA PRAHA AS's Therapeutic Areas

Disease areas where INTERPHARMA PRAHA AS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

INTERPHARMA PRAHA AS Pipeline Snapshot

Active clinical trials for INTERPHARMA PRAHA AS across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling